دانشگاه علوم پزشکی ایران
Iran University of Medical Sciences

مقالات لاتین

 | تاریخ ارسال: ۱۳۹۶/۳/۱ | 
2018
 
  1. In Vitro Cytotoxicity of Folate-Silica-Gold Nanorods on Mouse Acute Lymphoblastic Leukemia and Spermatogonial Cells.
  1. Human telomerase reverse transcriptase protein expression predicts tumor aggressiveness and survivain patients with cleacell renacell carcinoma.
LeilSaeednejad Zanjani, Zahra Madjd, Maryam Abolhasani, Ahmad Shariftabrizi, Arezoo RastiØystein Fodstad, Mojgan Asgari, Oct 2018. Pathology
 
  1. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in RenaCell Carcinomas.
Arezoo Rasti, Mitra Mehrazma, Zahra Madjd*, Maryam Abolhasani , LeilSaeednejad Zanjani,  Mojgan Asgari.Scientific reports, August 2018
 
  1. 3D Protein-BaseBilayeArtificial Skin for GuideScarless Healing of 3rd degreBurn Wounds In vivo.
Gholipourmalekabadi M, Seifalian AM, Urbanska AM, Omrani MD, HardJG, Madjd Z, Hashemi SM, Ghanbarian H, Brouki MilaP, Mozafari M, Reis RL, Kundu SCSamadikuchaksaraei A. Biomacromolecules. 2018 Mar 12
 
  1. Increaseexpression of CD44 is associated with more aggressive behavior in cleacell renal cell carcinoma.
Zanjani LSMadjZ, Abolhasani M, Rasti A, Fodstad O, Andersson Y, Asgari M. Biomark Med. 2018 Jan
 
2017
 
  1. Expression of CD105 cancer stecell marker in three subtypes of renal cell carcinoma. Zanjani LSMadjd Z, Abolhasani MShariftabrizi A, Rasti A, Asgari M. CanceBiomark. 2017 Dec 20
 
  1. Circulating cancer stecell markers in breast carcinomas: a systematic review protocol.
Mansoori M, Madjd ZJanani L, Rasti A. Syst Rev. 2017 Dec
 
  1. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomaand worse progression-free survivaicleacell renal cell carcinoma"
Rasti A, Madjd Z, · Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L. Asgari A, Clinical and Experimental Medicine, Dec 2017
 
  1. ExosomamicroRNAas potential circulating biomarkers in gastrointestinatract cancers: a systematireview protocol.  
Gheytanchi E, Madjd ZJanani L, Rasti A, Ghods R, Atyabi FLari MHABabashaSSyst Rev. 2017 Nov 17;6(1):228.
 
  1. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness iclear cell renacell carcinoma.  
Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M. Exp Mol Pathol. 2017 Oct 16;103(2):218-228.
 
  1. Lgr5High/DCLK1Higphenotype is more common in early stagand intestinal subtypes of gastricarcinomas.  
Elham Kalantaria, MohammaH. Asadi Larib, Raheleh Roudia, Alireza Korourianc and ZahrMadjd. CanceBiomarkers. 2017 Oct
 
  1. MicroRNA-31 inhibitRhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinomcells.  
Korourian A, Roudi R, Shariftabrizi A, Madjd Z. ExBiol Med (Maywood). 2017 Sep
 
  1. CanceStem Cell Research in Iran: Potentials and Challenges,
Raheleh Roudi, Marzieh Ebrahimi, AhmaShariftabrizi, ZahrMadjd , Future Oncology, 2017 August.
 
  1.  Cancer stem cell’s potential clinical   implications.
  1. Co-Expression of Putative Cancer SteCell Markers CD44 and CD133 in Prostate Carcinomas, : Pathology oncologresearch,
Kalantari E, Asgari M, NikpanaSSalarieh N, Asadi Lari MH, Madjd Z, 2017
 
  1. Possible involvement of CREB/BDNF signaling pathway in neuroprotectiveffects of topiramate against methylphenidate induceapoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidenceMotaghinejad M, Motevalian M, Babalouei F, Abdollahi M, Heidari M, Madjd Z.Brain ReBull. 2017 May 24;132:82-98
 
  1. Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNPathwain Rats, Neurotoxicity research.
Motaghinejad M, Motevalian M, Abdollahi M, Heidari M, Madjd Z. 2017
 
  1. Reduceexpression of CXCR4, a novel renacancer stecell marker, is associated with high-grade renacell carcinoma.
A Rasti, M Abolhasani, LZanjani, M Asgari, M Mehrazma, Z Madjd. Journal of Cancer Researcand Clinical Oncology, 2017, 1-10
 
2016
 
  1. Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stecell marker, using immunoassay basemethods.
A Mirzaei, Z Madjd, AKadijani, M Tavakoli-Yaraki, MH Modarresi, CanceBiomarkers, 2016, page 1-11
 
  1. Differential role of Wnt signalinand base excision repair pathways in gastric adenocarcinoma aggressiveness.
Korourian A, Roudi RShariftabrizi A, Kalantari E, Sotoodeh KMadjd Z. CliExp Med. 2016 Dec 1
 
  1. Coenzyme Q10 Ameliorates Trimethyltin Chloride Neurotoxicity in Experimental Model of Injury in Dentate Gyrus of Hippocampus: A Histopathological and BehavioraStudy.
MH Sakhaie, M Soleimani, V Pirhajati, SS Asl, Z Madjd, M MehdizadehIranian Red Crescent MedicaJournal, 2016
 
  1. Probiotic feedinaffects T cell populations in blood and lymphoid organs in chickens. Asgari FMadjd ZFalak R, Bahar MA, Nasrabadi MH, Raiani M, Shekarabi M. Benef Microbes. 2016 Jun 28:1-8
 
  1. Expression of CD133 cancer stecell marker in melanoma: a systematireview and meta-analysiS.
ZahrMadjd, Elham Erfani, Elmira GheytanchiMaziar MoradiLakeh, AhmaShariftabrizi , Mohsen Asadi-Lari.  Int J Biol Markers 2016.
 
  1. Evidence foembryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lunadenocarcinoma.
Roudi R, Madjd Z, Ebrahimi M, Najafi A, Korourian AShariftabrizi A, Samadikuchaksaraei A. Tumour Biol. 2016 Apr 5.
 
  1. Expression of Cancer SteCell Markers OCT4 and CD133 in Transitional Cell Carcinomas.  
SedaghaS, Gheytanchi E, Asgari M, Roudi R, Keymoosi H, Madjd Z. Appl Immunohistochem Mol Morphol. 2016 Mar 3.
 
  1. Accuracy of c-KIT in Lung Cancer Prognosis; a Systematic Review Protocol".
Roudi R, Kalantari E, Keshtkar A, Madjd Z. AsiaPac J Cancer Prev. 2016;17(2):863-6.
 
  1. Increased Expression of ALDH1A1 in Prostate Cancer is CorrelateWith Tumor Aggressiveness: A Tissue MicroarraStudy of Iranian Patients.
Kalantari ESaadi FH, Asgari M, Shariftabrizi A, Roudi RMadjd Z. Appl Immunohistochem Mol Morphol. 2016 Feb 18.
 
  1. Diagnostic and prognostic accuracy of miR-21 in renacell carcinoma: a systematireview protocol.  
Rasti A, Mehrazma M, Madjd Z, KeshtkaAA, Roudi RBabashaS.BMJ Open. 2016 Jan
 
 
  1. Impaired Memorand Evidence of Histopathology in CA1 Pyramidal Neurons througInjection of Aβ1-42 Peptides into the Frontal Cortices of Rat. Eslamizade MJMadjd Z, Rasoolijazi H, SaffarzadeFPirhajati V, Aligholi H, Janahmadi M, Mehdizadeh M. Basic Clin Neurosci. 2016 Jan;7(1):31-41.
 
  1. Evaluation of anaplastic lymphoma kinase (ALKexpression in nonsmall cell lung cancer; a tissue microarraanalysis.
Raheleh Roudi,Gholamreza HajiZahrMadjd, AhmaShariftabrizi, Mitra Mehrazma. Journal of Cancer Researcand Therapeutic. 2016
 
2015
 
  1. Comparative gene-expression profiling of CD133+  and CD133-  D10 melanoma cells. Roudi R, Ebrahimi M, Sabet MN, Najafi A, Nourani MRFomeshi MRSamadikuchaksaraei A,  Shariftabrizi A, Madjd ZFuture Oncol (IF=2.5). 2015 Aug 19:1-11 (Corresponding author)
 
 
  1. A new insight intcancer stem cell markers: Could locaand circulatincancer stem cell markers correlate in colorectal cancer
Mirzaei A, Tavoosidana G, Rad AA, RezaeF,  Tavakoli-Yaraki M, Kadijani AA, Khalili E, Madjd Z.Tumour Biol. 2015 Sep 17
 
  1. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1  in  various  skin  cancer  subtypes,  
Elham  Erfani1, Raheleh  Roudi, Azadeh Rakhshan, Mehrdad NasrollahzadeSabet, AhmaShariftabriziZahra Madjd, Int J Biomedical Markers.2015. (Corresponding author)
 
  1. 33. A Simple, Rapid, and Efficient Method foIsolating Mesenchymal Stem Cells from  the  Entire  Umbilical  Cord.   
Dehkordi  MB,  Madjd  Z,  Chaleshtori  MH, Meshkani   R,   Nikfarjam   L,   Kajbafzadeh   A.   Cell   Transplant.   2015   Aug 12(Correspondinauthor)
 
 
  1. PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy.  
Komeili-Movahhed T, FouladdeSBarzegar E, Atashpour S, Hossein Ghahremani M, Nasser OstaSMadjd Z, Azizi E.Iran J Basic MeSci. 2015 May;18(5):472-7.
 
  1. Differential expression of cancer stecell markerALDH1 and CD133 in various lung cancer subtypes,
Raheleh Roudi, Alireza Korourian, AhmaShariftabrizi, and ZahrMadjd. CanceInvest (IF=2.06). 2015 Jun 5. ( corresponding Author)
 
  1. StudoNGEexpression in androgen sensitive prostate cancecells: A potential target for immunotherapy.   
Mohsenzadegan M, Tajik N, Madjd ZShekarabi M, Farajollahi MM. Med J Islam Repub Iran. 2015 Jan 13;29:159
 
 
  1. StudoNGEexpression pattern in cancerous tissues provides noveinsights into prognostic marker in prostate cancer.   
Mohsenzadegan M, Shekarabi M, Madjd Z, Asgari M, Abolhasani M, Tajik N, Farajollahi MM. Biomark Me(IF=2.5). 2015; 9(4):391-401.
 
  1. Effecof Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma).
Karimi A, Majidzadeh-KMadjd Z, Akbari AHabibL, Akrami SM. Biol Trace EleRes (IF=1.5). 2015 Jun;165(2):131-4.
 
  1. Upregulation of circulating cancer stecell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treatecolorectal cancepatients.  
Mirzaei A, Tavoosidana G, Modarressi MH, Rad AAFazeli MSShirkoohi R, Tavakoli-Yaraki M, Madjd Z. Tumour Biol(IF=2.8) 2015 Jan 29. (Corresponding author)
 
 

2014
  1. Tissue microarrays, a revolution in pathology research,
ElhaKalantari , ZahrMadjd, BCCR, 2014. (Correspondinauthor).
 
  1. 41. Prognostic  relevance  of  putative  cancer  stem  cell  marker,  CD44  in  different histological  sub-typeof lung cancer.
Raheleh Roudi, ZahrMadjd, Alireza Korourian,  Mitra   Mehrazma,  Ahmad  Shariftabrizi,  SaadatMolanae.   CanceBiomarkers 14 (2014) 457–467 (IF= 1.18) (Corresponding author).
 
  1. 42. Co-Expression of PutativCancer SteCell Markers, CD133 and Nestin, in Skin Tumors.
Mehrdad  Nasrollahzadeh  Sabet , Azadeh  Rakhshan ,   Elham   Erfani , ZahrMadjd, AsiaPac J Cancer Prev, 15 (19), 8161-8169. (IF= 1.27) (Correspondinauthor)
 
  1. Tissue Microarray-based investigation PLAC1 expression in Prostate Carcinoma.
Roya Ghods, Mohammad Hossein Ghahremani, ZahrMadjd , Mojgan Asgari
Maryam Abolhasani, Sanaz Tavassoli , Ahmad Reza Mahmoudi, Mahmood Jeddi-Tehrani, Maryam Darzi, Amir-Hassan Zarnani, CanceImmunology
Immunotherap(IF=3.94), 201Sep 4.
 
  1. comparative study of mesenchymal stecell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. 
Aali E, Mirzamohammadi S, Ghaznavi H, Madjd ZLarijani B, RayegaSSharifi AM.J Diabetes Metab Disord. 2014 Aug 11;13(1):76. doi: 10.1186/2251-6581-13-76.
 
 
  1. 45. Exposure of hepatocellular carcinomcells to low-level As2O3   causeaextra toxicity pathway via Lretrotransposition induction.   
Karimi A, Madjd Z, Habibi L, Akrami SM. Toxicol LettIF=3.5). 2014 Jun 21; 229(1):111-117.
 
  1. Evaluating the Extent of LINE-1 MobilitFollowing Exposure to Heavy Metals in HepG2 Cells.     
Karimi A, Madjd Z, Habibi L, Akrami SM. Biol Trace Elem Re(IF=1.5). 2014 Jul;160 (1):143-51. 2014 Jun 5. ( Corresponding Author)
 
  1. Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma.     
Gheytanchi E, Mehrazma M, Madjd Z. AsiaPac J CancePrev ( IF=1.27). 2014; 15 (7): 3065-70.
 
  1. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with  poor prognosis in urotheliacarcinoma of the urinary bladder.  
Keymoosi H, Gheytanchi E,  Asgari M, Shariftabrizi A, Madjd Z. AsiaPac J Cancer Preventation (IF=1.27). 2014; 15(5):2013-20. (Correspondinauthor)
 
  1. Expression of EMSY, a noveBRCA2-link protein, is associated with lymph node metastasis and increased tumour size in breast carcinomas.  
ZahrMadjd, Mohammad E. Akbari; AmiHassan Zarnani, Maryam Khayazadeh, Elham Kalantari, Nazanin Mojtabavi., AsiaPacific J CaPrevention( IF=1.27), Volume 14, Issue 4 (Corresponding author)
 
2013
 
  1. The expression of p53 and MDM4 in oral, laryngeaand cutaneous squamous cell carcinoma: A comparative studby tissue microarray
Sami Jabar, Seta Sarkis, ZahrMadjd, Elham Kalantari, EuropeaScientific Journal, December 2013
 
  1. CD44 and CD24 markercannot acacancer stem cell markers ihumalunadenocarcinomcelline A549.  
RaheleRoudiMarzieEbrahimiAlSamadikuchaksaraei, ZahrMadjd. CELLULAR & MOLECULAR BIOLOGY LETTERS (IF=1.9), 13 Dec 2013. (Correspondinauthor)
 
  1. Evaluation of methylation of MGMT (O6- methyguanine methyltransferase)gene promoter by Methylation Specific-PCR in meningiomas witatypical features
and itcomparison between tumor gradeI, IIand III
LeilLarijani, ZahrMadjd et al, accepted to be included in AsiaPacific J CaPrevention ( IF=1.27), Volume 14, Issue 2.
 
  1. Expression of prostate stem cell antigen (PSCA) in prostate cancer; a tissue microarray studoIranian patients.
Jaleh Taeb, Mojgan Asgari, Maryam Abolhasani, Mohammad M Farajollahi, ZahrMadjdPathol RePract ( IF=1.4). 2013 Oct 11 ( Correspondinauthor)
 
  1. Reduceexpression of NGEP is associated with higgrade prostate cancers: a tissue microarraanalysis.  
Monireh Mohsenzadegan , ZahrMadjd, Mojgan Asgari, Maryam Abolhasani, Mehdi Shekarabi , Jaleh Taeb, AhmaShariftabrizi, CanceImmunology Immunotherapy, CanceImmunology Immunotherapy ( IF=3.94). 2013 Oct; 62 (10) ( Correspondinauthor)
 
 
  1. Application of Stem Cells in Targeted TherapoBreast Cancer: A Systematic ReviewMadjd Z, Gheytanchi E, Erfani E, Asadi-Lari M. AsiaPac J CancePrev. 2013;14(5):2789-2800. (Corresponding Author)
 
 
  1. Chronic Ritalin Administration during Adulthood IncreaseSerotonin Pool in Rat Medial Frontal Cortex.Daniali
S, Nahavandi A, Madjd ZShahbazi A, NiknazaSShahbazzadeh D. IraBiomeJ. 2013 Jul;17(3):134-9.
 
  1. Expression of stem cell markers, CD133 and CD44 in pediatric solid tumours, a study using Tissue microarray.  
Mitra MehrazmaZahra Madjd, Elham Kalantari, Mahshid  Panahi, Alireza Hendi. Fetal Pediatr Pathol. 2013 Jun; 32(3):192-204.
 
2012
  1. High  expression  of  stem  cell  marker  ALDH1  is  associated  with  mutated BRCA1in invasive breascarcinomas,
ZahrMadjdBabak Ramezani , Mohsen Asadi  Lari,   Saadat  Molanae,  Asian  Pac  J  Cancer  Prev.  2012;13(6):2973-8 (Corresponding Author)
 
  1. Do clinical  and  demographic  features  of  patients  with  upper-gastrointestinacanceaffect  their health-related  quality of life
Ali Esmaili-Hesari, Fatemeh Homai, Abbas Motevallian, ZahrMadjd, Masoud Solaymani-Dodaran, Mohsen
Asadi-Lari. Int J Prev Med. 2012 Nov; 3(11):783-90.
 
 
  1. The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays.     
  1. Apelin-13 Protects the Brain Against Ischemic Reperfusion Injurand Cerebral Edema in a Transient Model of Focal CerebraIschemia.   
  1. Occult Hepatitis C ViruInfection in Iranian Patients with Chronic Liver Disease with Unknown Etiology,   
FaraBokharaeSalim, Hossein keyvani, Seyed Moayed Alavian, SeyeHamid Reza MonavariZahrMadjd, Mohsen Nasiri Tousi, Amir Houshang AlizadehJournal of Medical Virology, 2011, June (IF=2.5).

  1. Neuroprotective EffecoExogenous Melatonion Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats.   
Fereshteh Mehraein, Reza Talebi, Behnamedin Jameie, Mohammad Taghi Joghataie and Zahra MadjdIraniaBiomedicaJournal 15 (1 & 2): 44-50 (April & January 2011).
 
  1. BRCA1 protein expression level and CD44+ phenotype in breast cancepatients.
ZahrMadjd, AdeKarimi, Saadat Molanae, Mohsen Asadi-Lari. CELJOURNAL (Yakhteh)Vol 13, No 3, Autumn 2011 ( Corresponding Author)
 
  1.  Immunohistochemical   localization   of   endothelial   nitric   oxide   synthase   in testicular  cells  of  men  with  non-  obstructive  azospermia,
Khadijeh  Foghi  , Marefat  Ghaffari  Novin.,  Zahra  Madjd,  Tohid  Najafi.,  Mohammad  Hasan Heidari.,   Abouzar   Rostampour   Yasoori.       Iranian   Journal   of   Reproductive Medicine Vol.9. No.4. pp:277-280, Autumn 2011.
 
  1. Expression of BRCA1 Protein iInvasive and ISitu Carcinomaand itRelation with  Marker of  Breast  CanceStem  Cells  (CD44) and  Prognostic Factors  in Breast Cancer Patients.
Madjd Z, Karimi A, Hashemi F, Molanae S, RazJournal of MedicaSciences Vol. 17, No. 80 & 81, Feb/Mar 2010-2011 ( IPersian)
 
  1. The immunohistochemical assessment of ALDH1 activity in breast canceand it’s correlation with  pathologic features.
Babak Ramezani, Zahra Madjd, Maryam KadivarSaadat Molanae.  Tehran  UniversitMedicaJournal; Vol. 69, No. 9, December 2011: 529-536IPersian)
 
 
  1. 2009
  1. CD44+ cancecellexpress higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.
Madjd ZZare Mehrjerdi ASharifi A , MolanaeSZohourian S, Asadi Lari M. CanceImmunity. April 2009.vol9.p4.
 
  1. The Concept of Palliative Care Practicamong  Iranian General  Practitioners.
Asadi-Lari M, Madjd Z, Afkari ME, Goushegir A, Baradaran HR. Iranian Journal of Cancer Prevention. Vol.2, No 3, summer 2009.
 
  1. OCT4, aembryonic stecell marker, is expressed in breast, brain and thyroid carcinomacompared to testiculacarcinoma.
Madjd Z, Hashemi FShayanfar N, Farahani E , Zarnani AH,  Sharifi AM. Iranian Journal of CancePrevention. Vol.2, No 4, autum 2009.
 
2008
 
  1. The need for palliative care services in Iran; aintroductorcommentary.
AsadiLari M, Madjd Z, Akbari ME. Iranian Journal of CancePrevention. Vol.1, No1, 1-5, .2008. Jan
 
  1. Spirituacare at the end of life in the Islamic context, a systematic review
AsadiLari M, Madjd Z, Gooshegir.  Iranian Journal of CancePrevention. Vol.1, No 2, July 2008.
 
  1. Gaps in the provision of spiritual care for terminally ill patients in Islamic societies, a systematireview.
Mohsen Asadi-Lari, Zahra Madjd, Sayyed Ashrafeddin Goushegir. Advances in Palliative Medicine 2008, 73–80.
 
2007
 
  1. The ubiquitin-binding protein p62 is expressed in breast cancers showinfeatures of aggressive  disease.
Rolland P, Madjd Z, Durrant L, Ellis IO, Layfield R, Spendlove I. Endocrine  Related Cance(IF: 5.193). 2007 Mar;14(1):73-80.
 
  1. Up-regulation of MICA on high-grade breast carcinomas.
Madjd ZPinder SE, Spendlove I,  Watson NFS, Moss R, BevaS, Durrant LG. Cancer immunity,2007
2006
 
  1. Expression of the stress related protein MICA is an independent indicator ogood prognosis in colorectal cancer patients.
Watson NFSSpendlove IMadjd Z, Moss R, Green A, Ellis IO, Durrant LGScholefield JH. International J Cance(IF: 5.007). 200Mar 15118(6):1445-52.
 
  1. Cytoplasmiexpression p27 KIP-1  is associated with a favourable prognosis in colorectacancepatients.
NFWatson, LG Durrant,  JScholefield, Z Madjd, D  Scrimgeour,  I  Spendlove,  IO  Ellis,  PM  Patel.            World  J  Gastroenterolog(IF=2.433). 2006 Oct 21,12(39).
 
  1. The  p53  Positive  Bcl-2  Negative  Phenotype  is  an  independent  marker  of prognosis in breast cancer.
Phil Rolland, IaSpendlove, ZahrMadjd, Emad A Rakha, ,Patel Poulam, Ian  O. Ellis, Lindy Durrant. International J Cance(IF:5.007), 22 Dec 2006 .
 
  1. Immunosurveillance is active in colorectal canceas downregulation but not complete loss of MHC Class I expression correlates with a poor prognosis in early stage patients.
Watson NFS, RamagJMadjd ZSpendlove I, ElliIO, Scholefield J, Durrant LG. Int J Cance(IF: 5.007)  . 2006 Jan 1; 118(1)6-10.
 
2005
 
  1. Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: A tissue microarray study of 460 patients.
Watson NFSMadjd Z, ElliIO, Scholefield JSpendlove I. Durrant LG. World J Surg Oncolog(IF: 1.20). 200Jul 19; 3:47.
 
  1. Expression of the Membrane Complement RegulatorProtein CD59 (Protectin) is Associated with ReduceSurvivain Colorectal Cancer patients.
Watson NFS, Durrant LG, Madjd ZEllis IO, Scholefield Jand Spendlove I. CanceImmunology Immunotherapy (200IF: 4.8)  . 200Sep 3;1-8
 
  1. Over-expression of Lewiy/b antigens is associated with decreased survivailymph node negative breast carcinomas.
Madjd ZParsons T, Watson NFSSpendlove I, ElliIand Durrant LG. Breast Cancer Research. (IF: 5.88); 7(5):R780-7. 2005 Jul 28.
  1. Do poor prognosis breast tumours express membrane cofactor proteins (CD46)?
Madjd  Z,  Durrant  LG,  Pinder  SE,  Ellis  IO,  Ronan  J,  Rushmere  NK  and
Spendlove. CanceImmunology Immunotherap(IF: 4.8), 2005;54(2):149-56
 
  1. Totaloss of MHC class I molecules is an independent indicator of good prognosis in breast cancersMadjd ZPinder SE, Spendlove I, ElliIO, and Durrant LG. International J Cance(IF: 5.007). 2005 Nov 1; 117(2): 248-55.
 
2003- 2004
 
  1. Loss of CD55 is associated with aggressive breast tumours.
Madjd Z, Durrant LG, Bradley R, Spendlove I, ElliIO, Pinder SE. Clinical Cancer Researc(IF:9.625), 2004, 10: 2797-2803
  1. Loss of CD59 expression in breast tumours correlates with poor survival.
Madjd ZPinder S E, Paish C, ElliIO, CarmichaeJ, Durrant L G. J Pathology(IF:6.9), 2003, 200: 633-639.
 
 

دفعات مشاهده: 1618 بار   |   دفعات چاپ: 162 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر